Chronic obstructive pulmonary disease and subsequent overall and lung cancer mortality in low-income adults

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Aldrich, Melinda C ^a   Munro, Heather M ^b   Mumma, Michael ^b   Grogan, Eric L ^a,c   Massion, Pierre P ^d   Blackwell, Timothy S ^e   Blot, William J ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c Veterans Affairs Tennessee Valley Health Care System   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASTHMA; BLACK PERSON; BODY MASS; BYPASS SURGERY; CANCER MORTALITY; CANCER SURVIVAL; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; LOWEST INCOME GROUP; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PREVALENCE; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; UNITED STATES; COHORT ANALYSIS; COMPLICATION; ECONOMICS; EPIDEMIOLOGY; LUNG TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; POVERTY; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POVERTY; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; UNITED STATES;

EID: 84926368009     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121805     Document Type: Article

References (37)

1. Brenner DR, Boffetta P, Duell EJ, Bickeboller H, Rosenberger A, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol. 2012; 176: 573-585. PMID: 22986146
2. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011; 103: 1058-1068. doi: 10.1093/jnci/djr173 PMID: 21606442
3. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007; 176: 285-290. PMID: 17478615
4. Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer. 2013; 13: 233-245. doi: 10.1038/nrc3477 PMID: 23467302
5. Shin JI, Brusselle GG. Mechanistic links between COPD and lung cancer: a role of microRNA let7? Nat Rev Cancer. 2014; 14: 70. PMID: 24505620
6. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Resp J. 2009; 34: 380-386.
7. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol. 2011; 12: 399-408. doi: 10.1016/S1470-2045(10)70126-1 PMID: 20951091
8. Kiri VA, Soriano J, Visick G, Fabbri L. Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database. Prim Care Resp J. 2010; 19: 57-61. doi: 10.4104/pcrj.2010.00016 PMID: 20191261
9. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst. 2009; 101: 554-559. doi: 10.1093/jnci/djp023 PMID: 19351920
10. Chronic obstructive pulmonary disease among adults - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012; 61: 938-943. PMID: 23169314
11. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011;(63:) : 1-8. PMID: 22142836
12. Zhai R, Yu X, Shafer A, Wain JC, Christiani DC. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest. 2014; 145: 346-353. doi: 10.1378/chest.13-1176 PMID: 24008835
13. Chamberlain AM, Schabath MB, Folsom AR. Associations of chronic obstructive pulmonary disease with all-cause mortality in Blacks and Whites: the atherosclerosis risk in communities (ARIC) study. Ethn Dis. 2009; 19: 308-314. PMID: 19769014
14. Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011; 65: 26-34. doi: 10.1136/jech.2009.089722 PMID: 19854747
15. Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, et al. Racial differences in CT phenotypes in COPD. COPD. 2013; 10: 20-27. doi: 10.3109/15412555.2012.727921 PMID: 23413893
16. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 2003; 254: 540-547. PMID: 14641794
17. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012; 379: 1341-1351. doi: 10.1016/S0140-6736(11)60968-9 PMID: 22314182
18. Willyard C. Diagnosis: To catch a killer. Nature. 2012; 489: S8-S9. doi: 10.1038/489S8a PMID: 23013716
19. Signorello LB, Hargreaves MK, Blot WJ. The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved. 2010; 21: 26-37. doi: 10.1353/hpu.0.0354 PMID: 20675943
20. Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, et al. Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc. 2005; 97: 972-979. PMID: 16080667
21. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994; 10: 77-84. PMID: 8037935
22. Stein BD, Bautista A, Schumock GT, Lee TA, Charbeneau JT, et al. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2012; 141: 87-93. doi: 10.1378/chest.11-0024 PMID: 21757568
23. Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res. 2011; 11: 43. doi: 10.1186/1472-6963-11-43 PMID: 21345188
24. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Resp J. 2006; 28: 1245-1257. PMID: 17138679
25. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Resp J. 2008; 32: 962-969. doi: 10.1183/09031936.00012408 PMID: 18579551
26. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5: 549-555. doi: 10.1513/pats.200709-148ET PMID: 18453370
27. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186: 155-161. doi: 10.1164/rccm.201201-0034OC PMID: 22561964
28. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160: 1683-1689. PMID: 10847262
29. Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012; 307: 1433-1435. doi: 10.1001/jama.2012.404 PMID: 22474208
30. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010; 7: 32-43. doi: 10.3109/15412550903499522 PMID: 20214461
31. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax. 2006; 61: 472-477. PMID: 16517577
32. Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care. 2004; 27: 2478-2484. PMID: 15451919
33. Miller JD, Foster T, Boulanger L, Chace M, Russell MW, et al. Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data. COPD. 2005; 2: 311-318. PMID: 17146996
34. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, et al. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature. COPD. 2006; 3: 211-218. PMID: 17361502
35. Balkan A, Bulut Y, Fuhrman CR, Fisher SN, Wilson DO, et al. COPD phenotypes in a lung cancer screening population. Clin Respir J. 2014 Jul 3. doi: 10.1111/crj.12180.
36. Young RP, Hopkins RJ. CT screening in COPD: impact on lung cancer mortality: de Torres JP, Casanova C, Marin JM et al. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study. Respir Med 2013; 107: 702-707.
37. Respi Med. 2014;108: 813-814. doi: 10.1016/j.rmed.2013.01.013 PMID: 23465176